Cost of preventable adult hospital stays topped $33 billion in 2017June 23, 2020Business of MedicineHeart FailureDiabetes
Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFRJune 18, 2020DiabetesHeart Failure
CV outcomes of SGLT2 inhibitors and GLP-1 agonists compared in real-world studyJune 14, 2020DiabetesHeart Failure
EMPA-REG OUTCOME: Empagliflozin cut insulin need in type 2 diabetesJune 13, 2020DiabetesHeart Failure
High-dose tafamidis boosts survival in transthyretin amyloidosis cardiomyopathyJune 8, 2020Heart Failure
More fatalities in heart transplant patients with COVID-19June 4, 2020Heart FailureCOVID-19 UpdatesInterventional Cardiology & SurgeryMixed Topics
FDA okays emergency use for Impella RP in COVID-19 right heart failureJune 2, 2020Heart FailureCOVID-19 UpdatesMixed Topics
